Pramana Pharmaceuticals Wins $1 Million for New Alzheimer’s Pill
Pramana Pharmaceuticals has been awarded $1 million to advance a new daily pill for Alzheimer’s disease. The funding from the Alzheimer’s Association will help move their drug, PRM-914, into human safety tests. This offers new hope for families and focuses on the gut-brain connection…